Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy

Abstract

A multimodal nanocarrier based on mesoporous silica nanoparticles (MSNs) is developed to co-delivery photosensitizer chlorin e6 (Ce6) and chemotherapeutic agent doxorubicin (Dox) for cancer combination therapy. Ce6 was covalently conjugated with mesoporous silica nanoparticles, which could increase the loading efficiency, and allowed for photodynamic therapy. Doxorubicin was loaded into the pores of mesoporous silica nanoparticles to afford the dual drug delivery system Dox@MSNs-Ce6. These hybrid nanoparticles have an average diameter of about 100 nm and slightly negative charge of about −17 mV. The Dox@MSNs-Ce6 nanoparticles could efficiently enter into cancer cells. The cellular reactive oxygen species level in treated cells increased about 17 times, upon 660 nm light irradiation (10 mW/cm², 2 min). More importantly, Dox@MSNs-Ce6 exhibited excellent synergistic effect through combining chemotherapy and photodynamic therapy against A549 lung cancer cells. Our work provides an effective strategy for anticancer drug delivery and combination therapy.

Keywords

Mesoporous silica nanoparticles drug delivery photodynamic therapy combination therapy cancer

Get full access to this article

View all access options for this article.

References

Siegel

Miller

and Jemal

Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7–30.

Jones

Cytotoxic chemotherapy: Clinical aspects. Medicine 2016; 44: 25–29.

Persidis

Cancer multidrug resistance. Nat Biotechnol 1999; 17: 94–95.

Sun

Wang

et al . Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev 2016; 98: 19–34.

Kemp

Shim

Heo

et al . Combo nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev 2016; 98: 3–18.

Kohli

and Smith

Nanoparticles for combination drug therapy. ACS Nano 2013; 7: 9518–9525.

Argyo

Weiss

Bräuchle

et al . Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery. Chem Mater 2014; 26: 435–451.

Aznar

Oroval

Pascual

et al . Gated materials for on-command release of guest molecules. Chem Rev 2016; 116: 561–718.

Lee

Kim

et al . Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc Chem Res 2011; 44: 893–902.

10.

Tang

and Chen

Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv Mater Weinheim 2012; 24: 1504–1534.

11.

Meng

Liong

Xia

et al . Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010; 4: 4539–4550.

12.

Meng

Mai

Zhang

et al . Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 2013; 7: 994–1005.

13.

Meng

Wang

Liu

et al . Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano 2015; 9: 3540–3557.

14.

Wang

Shi

et al . Multifunctional Znpc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Biomaterials 2012; 33: 7903–7914.

15.

Liu

Yang

Wang

et al . Hyperbranched polyglycerol-doped mesoporous silica nanoparticles for one- and two-photon activated photodynamic therapy. Adv Funct Mater 2016; 26: 2561–2570.

16.

Conte

Ungaro

Mazzaglia

et al. Photodynamic therapy for cancer: Principles, clinical applications, and nanotechnological approaches. In: Alonso M and Garcia-Fuentes M (eds) Nano-Oncologicals, 2014, pp.123–160. Cham: Springer.

17.

Dolmans

DEJGJ

Fukumura

and Jain

RK.

Photodynamic therapy for cancer. Nat Rev Cancer 2003; 3: 380–387.

18.

Cheng

S-H

Lee

C-H

Yang

C-S

et al . Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: Potential cancer theranostics. J Mater Chem 2009; 19: 1252–1257.

19.

Lin

et al . In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater 2009; 21: 172–177.

20.

Shen

Kim

H-C

et al . Cyclodextrin and polyethylenimine functionalized mesoporous silica nanoparticles for delivery of siRNA cancer therapeutics. Theranostics 2014; 4: 487–497.

21.

Shen

Liu

et al . Multi-step encapsulation of chemotherapy and gene silencing agents in functionalized mesoporous silica nanoparticles. Nanoscale 2017; 9: 5329–5341.

22.

Zhang

Shen

et al . Co-delivery of cisplatin prodrug and chlorine E6 by mesoporous silica nanoparticles for chemo-photodynamic combination therapy to combat drug resistance. ACS Appl Mater Interf 2016; 8: 13332–13340.

23.

Luo

Cai

et al . Mesoporous silica nanoparticles end-capped with collagen: Redox-responsive nanoreservoirs for targeted drug delivery. Angew Chem Int Ed 2011; 50: 640–643.

24.

Huang

Lin

Wang

et al . Photosensitizer-conjugated silica-coated gold nanoclusters for fluorescence imaging-guided photodynamic therapy. Biomaterials 2013; 34: 4643–4654.

25.

Pan

Liu

and Shi

Intranuclear photosensitizer delivery and photosensitization for enhanced photodynamic therapy with ultralow irradiance. Adv Funct Mater 2014; 24: 7318–7327.

26.

Xiao

Howell

et al . Porous silicon nanoparticle photosensitizers for singlet oxygen and their phototoxicity against cancer cells. ACS Nano 2011; 5: 3651–3659.

27.

Slowing

Vivero-Escoto

C-W

et al . Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008; 60: 1278–1288.

28.

Trewyn

Slowing

Giri

et al . Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol–gel process and applications in controlled release. Acc Chem Res 2007; 40: 846–853.

29.

Alexis

Pridgen

Molnar

et al . Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008; 5: 505–515.

30.

Slowing

Trewyn

and Lin

VSY.

Effect of surface functionalization of Mcm-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 2006; 128: 14792–14793.

31.

Yin

et al . Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010; 31: 3657–3666.

32.

Celli

Spring

Rizvi

et al . Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization. Chem Rev 2010; 110: 2795–2838.

33.

Stolik

Delgado

Pérez

et al . Measurement of the penetration depths of red and near infrared light in human “ex vivo” tissues. J Photochem Photobiol B, Biol 2000; 57: 90–93.

34.

Huang

Lin

Wang

et al . Light-triggered theranostics based on photosensitizer-conjugated carbon dots for smultaneous enhanced-fluorescence imaging and photodynamic therapy. Adv Mater 2012; 24: 5104–5110.

35.

Rotomskis

Valanciunaite

Skripka

et al . Complexes of functionalized quantum dots and chlorine E6 in photodynamic therapy. Lith J Phys 2013; 53: 57–68.

36.

Peng

Wei

et al . Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy. Angew Chem Int Ed 2013; 52: 1457–1461.

37.

Zhu

Liao

Bian

et al . Ph-controlled delivery of doxorubicin to cancer cells, based on small mesoporous carbon nanospheres. Small 2012; 8: 2715–2720.

38.

Lim

Y-B

Kim

S-M

Lee

et al.

Cationic hyperbranched poly (amino ester): A novel class of DNA condensing molecule with cationic surface, biodegradable three-dimensional structure, and tertiary amine groups in the interior. J Am Chem Soc 2001; 123: 2460–2461.

39.

Robertson

Evans

and Abrahamse

Photodynamic therapy (Pdt): A short review on cellular mechanisms and cancer research applications for Pdt. J Photochem Photobiol B 2009; 96: 1–8.

40.

Gong

Cheng

Xiang

et al . Near‐infrared absorbing polymeric nanoparticles as a versatile drug carrier for cancer combination therapy. Adv Funct Mater 2013; 23: 6059–6067.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.06 MB